Tubercolosis 2020 Dall’innovazione all’intervento, Institut Pasteur, Parigi, 14-18 settembre 2020

Nuove soluzioni di rilevamento della tubercolosi

Pateur Tuberculosis
Tuberculosis Pasteur

Il seminario / congresso EMBO Tuberculosis 2020 a Parigi sarà la terza grande conferenza sulla tubercolosi (TB) e i micobatteri patogeni che si terrà nel centro congressi (CIS) dell’Institut Pasteur nel 21 ° secolo, dopo i due precedenti EMBO di grande successo. conferenze sponsorizzate tenutesi nel 2012 e 2016 nella stessa sede. Poiché la situazione globale con la tubercolosi è purtroppo ancora molto lontana dall’essere risolta nonostante alcuni importanti progressi scientifici negli ultimi anni, e la tubercolosi rimane ancora una malattia infettiva chiave che sostiene globalmente più di 4000 vite umane ogni giorno, la ricerca di romanzi, scientificamente molto stimolante , le soluzioni a questa tragedia umana sono di interesse urgente e continuo. Pertanto, gli obiettivi di questo incontro sono unire una massa critica di scienziati coinvolti nella ricerca per comunicare e scambiare nuove informazioni sulla malattia e l’agente causale, nonché i micobatteri correlati che sono di interesse medico.
Sostenuto da

Pasteur
Pateur Institute

Institut Pasteur e Organizzazione europea di biologia molecolare

Invited Speakers

Laurent Abel, Inserm, Necker, Paris, France

Jacqueline Achkar, Albert Einstein College, New York, United States

Bree Aldridge, Tufts University, Boston, United States

Pedro Alzari, Structural Microbiology, Institut Pasteur, Paris, France

Kupz Andreas, James Cook University, Cairns, Australia

David Barros-Aguirre, GSK Medicines Development Centre, Tres Cantos, Spain

Clif Barry, NIH NIAID, Bethesda, United States

Marcel Behr, McGill University, Montreal, Canada

Daria Bottai, University of Pisa, Pisa, Italy

Priscille Brodin, INSERM, Institut Pasteur de Lille, Lille, France

Roland Brosch, Institut Pasteur, Paris, France

Mamadou Daffe, Institut de Pharmacologie et de Biologie Structurale, Toulouse, France

Bouke De Jong, Institute of Tropical Medicine, Antwerp, Belgium

Sabine Ehrt, Cornell Medical College, New York, United States

Helen Fletcher, London School of Hygien and Tropical Medicine, London, United Kingdom

Sarah Fortune, Harvard University, Boston, United States

Fabienne Girard-Misguich, Université de Versailles, ST-Quentin-en-Yvelines, France

Stephen Gordon, University College Dublin, Dublin, Ireland

Maximiliano G. Gutierrez, The Francis Crick Institute, London, United Kingdom

Willem Hanekom, Africa Health Research Institute (AHRI), Durban, South Africa

Simone Joosten, Leiden University, Leiden, The Netherlands

Vadim Makarov, A.N. Bach Institute of Biochemistry, Moscow, Russia

Giulia Manina, Institut Pasteur, Paris, France

Carlos Martin, University of Zargossa, Zaragossa, Spain

Helen McShane, University of Oxford, Oxford, United Kingdom

Carl Nathan, Cornell University, New York, United States

Olivier Neyrolles, Institut for Pharmacology and Structural Biology, Toulouse, France

Stefan Niemann, Research Center Borstel, Borstel, Germany

Anne O’garra, The Francis Crick Institute, United Kingdom

Lalita Ramakrishnan, University of Cambridge, Cambridge, United Kingdom

Santiago Ramon-Garcia, University of Zaragoza, Zaragoza, Spain

Eric Rubin, Harvard University, Boston, United States

David Russell, Cornell University, Ithaca, United States

Jan Rybniker, University of Cologne, Cologne, Germany

Sally A Sharpe, Porton Down, Salibury, United Kingdom

Ludovic Tailleux, Institut Pasteur, Paris, France

An van der Bossche, SienSano, Brussels, Belgium

Laura Via, NIH NIAID, Bethesda, United States

Gerhard Walzl, Stellenbosch University, Stellenbosch, South Africa
Local Organization committee

Roland Brosch (Chair), Institut Pasteur, Paris, France

Pedro Alzari (Co-Chair), Structural Microbiology, Institut Pasteur, Paris, France

Jean-Louis Herrmann (Co-Chair), Université Paris-Saclay, Versailles, France

Giulia Manina (Co-Chair), Institut Pasteur, Paris, France

Elodie Pysson, Institut Pasteur, Paris, France
International Scientific committee

Pedro Alzari, Structural Microbiology, Institut Pasteur, Paris, France

Clif Barry, NIH NIAID, Bethesda, United States

Priscille Brodin, INSERM, Institut Pasteur de Lille, Lille, France

Roland Brosch, Institut Pasteur, Paris, France

Sabine Ehrt, Cornell Medical College, New York, United States

Lalita Ramakrishnan, University of Cambridge, Cambridge, United Kingdom

Eric Rubin, Harvard University, Boston, United States

Institut Pasteur, 28 rue du Dr Roux, 75724 Paris Cedex 15, France

Comments are closed, but trackbacks and pingbacks are open.